Related Experiment Videos
Biglycan deficiency interferes with ovariectomy-induced bone loss
Karina L Nielsen1, Matthew R Allen, Susan A Bloomfield
1Nordic Bioscience A/S, Herlev, Denmark. kln@nordicbioscience.com
Summary
Biglycan deficiency protects female mice from ovariectomy-induced bone loss, revealing a gender-specific role in bone turnover. Biglycan-deficient mice show resistance to estrogen depletion effects on trabecular bone.
Area of Science:
- Skeletal Biology
- Extracellular Matrix Research
- Bone Metabolism
Background:
- Biglycan (bgn) is an extracellular matrix proteoglycan found in skeletal tissues.
- Biglycan-deficient male mice exhibit reduced bone mass and strength.
- Estrogen depletion via ovariectomy (OVX) is a key factor in bone loss.
Purpose of the Study:
- Investigate the bone phenotype of biglycan-deficient female mice.
- Determine the effect of estrogen depletion (OVX) on biglycan-deficient female mice.
- Explore the gender-specific role of biglycan in bone turnover.
Main Methods:
- Ovariectomy (OVX) or sham operations were performed on wildtype (wt) and biglycan-deficient (bgn KO) mice.
- Bone mass and turnover were assessed using pQCT, biochemical markers, and histomorphometry.
- Analysis included bone mineral density, bone volume, mineral apposition rate, and resorption markers.
Main Results:
- Biglycan deficiency did not significantly affect bone metabolism in female mice under normal conditions.
- OVX induced significant bone loss in wt mice but not in bgn KO mice.
- Bgn KO OVX mice showed no increase in bone resorption markers compared to controls.
- Serum OPG levels were elevated and RANKL levels decreased in bgn KO mice.
Conclusions:
- Biglycan deficiency confers resistance to OVX-induced trabecular bone loss in female mice.
- A significant gender difference exists in the response to biglycan deficiency and OVX.
- Biglycan plays a role in modulating both bone formation and resorption, influencing overall bone turnover.